
Sign up to save your podcasts
Or


Okava has been investigating the use of GLP-1 receptors in cats and found it has similar effects to weight-loss drugs on humans.
The San Francisco-based company is hoping to develop a long-acting implant as opposed to regular injections.
But, Healthy Pets New Zealand trustee and vet Dr Cath Watson says weight loss drugs should not be the first option for pets.
Watson told Andrew Dickens that pet obesity levels are "pretty bad and getting worse".
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
By Newstalk ZB5
11 ratings
Okava has been investigating the use of GLP-1 receptors in cats and found it has similar effects to weight-loss drugs on humans.
The San Francisco-based company is hoping to develop a long-acting implant as opposed to regular injections.
But, Healthy Pets New Zealand trustee and vet Dr Cath Watson says weight loss drugs should not be the first option for pets.
Watson told Andrew Dickens that pet obesity levels are "pretty bad and getting worse".
LISTEN ABOVE
See omnystudio.com/listener for privacy information.

40 Listeners

22 Listeners

10 Listeners

25 Listeners

3 Listeners

56 Listeners

2 Listeners

5 Listeners

0 Listeners

13 Listeners

94 Listeners

4 Listeners

54 Listeners

1 Listeners

4 Listeners

0 Listeners

1 Listeners

26 Listeners

114 Listeners

0 Listeners

0 Listeners

0 Listeners

3 Listeners

0 Listeners

0 Listeners

9 Listeners

6 Listeners

70 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

2 Listeners

5 Listeners